NCT02592200已完成不适用
A Double Blind Placebo-Controlled Study on the Effect of the Probiotic Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women - Proof of Concept
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- BioGaia AB
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Change in frequency of complete spontaneous bowel movements (CSBMs)
研究概览
简要总结
The primary objective is to determine the change in frequency of complete spontaneous bowel movements (CSBMs) after 4 weeks of oral supplementation with Lactobacillus gasseri DSM 27123 in healthy adult women with functional constipation.
详细描述
Subjects to complete study diaries, number of SBM, CSBM, form of faeces (according to the Bristol Stool Form scale), pain during defecation (according to the visual analogue scale [VAS] 0-100), time spent at each evacuation, episodes of faecal incontinence, number of ingested capsules of investigational product will be recorded daily by the subjects
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 49 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •The subjects have to meet all of the following criteria to be eligible to enter the study:
- •Willing and able to provide informed consent
- •Women aged 18-49 years at Visit 1
- •BMI ≥18 and ≤29 at Visit 1
- •Suffering of functional constipation as defined by the Rome III criteria for functional constipation
- •Comply with the requirement not to use any other probiotic products from Visit 1 and throughout the study period
- •Not pregnant or breastfeeding
- •Using adequate contraceptive measures
- •Ability to understand and comply with the requirements of the study, as judged by the Investigator
排除标准
- •Hypersensitivity or allergy to the investigational product, to chemically related products or to comparator/placebo
- •Well-known, organic cause of constipation
- •Anorectal pathology
- •Previous gastrointestinal surgery
- •Any alarming symptoms (i.e. rectal bleeding, weight loss, jaundice) as judged by the Investigator
- •Spinal anomalies and injuries
- •Use of antibiotics within 4 weeks prior to Visit 1
- •Use of products containing probiotics more than once a week in the previous 3 weeks
- •Mental or behavioural disorders as judged by the Investigator
- •Food allergy
结局指标
主要结局
Change in frequency of complete spontaneous bowel movements (CSBMs)
时间窗: Baseline and 4 weeks
次要结局
- Presence of Lactobacillus gasseri DSM 27123 in faeces(4 weeks)
- Change in Stool Consistency (Bristol Stool Form scale)(Baseline, week 1, 2, 3 and 4)
- Change in Patient-Assessment of Constipation Symptoms (PAC-SYM)(Baseline, week 1, 2, 3 and 4 (change from baseline))
- Change in Gastrointestinal Symptom Rating Scale (GSRS)(Baseline, week 1, 2, 3 and 4)
- Proportion of responders(4 weeks)
- Number of participants with treatement related adverse events(During the whole study - 4 weeks)
- Need for laxative medication(During the treatment period - 4 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic TreatmentAntibiotic Associated DiarrheaNCT01941160KGK Science Inc.160
已完成
2 期
Effect of TU-100 in Patients With Functional ConstipationFunctional ConstipationNCT01348152Tsumura USA50
已完成
3 期
Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength During Locomotion in Chronic Hemiparetic PatientsCOMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBONCT01821573Assistance Publique - Hôpitaux de Paris36
已完成
2 期
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)Diarrhea-predominant Irritable Bowel SyndromeNCT03977155Boston Pharmaceuticals133
已完成
2 期
An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional ConstipationFunctional ConstipationNCT02418507KGK Science Inc.100